EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 163 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2023. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $275,000 | -42.9% | 5,927 | -50.3% | 0.03% | -43.1% |
| Q3 2017 | $482,000 | +19.3% | 11,927 | 0.0% | 0.05% | +18.6% |
| Q2 2017 | $404,000 | +16.8% | 11,927 | 0.0% | 0.04% | +16.2% |
| Q1 2017 | $346,000 | -11.7% | 11,927 | 0.0% | 0.04% | -19.6% |
| Q4 2016 | $392,000 | +4.3% | 11,927 | 0.0% | 0.05% | 0.0% |
| Q3 2016 | $376,000 | +12.2% | 11,927 | 0.0% | 0.05% | +15.0% |
| Q2 2016 | $335,000 | -22.8% | 11,927 | 0.0% | 0.04% | -16.7% |
| Q1 2016 | $434,000 | -9.0% | 11,927 | 0.0% | 0.05% | +2.1% |
| Q4 2015 | $477,000 | +40.3% | 11,927 | 0.0% | 0.05% | +38.2% |
| Q3 2015 | $340,000 | -13.5% | 11,927 | 0.0% | 0.03% | +30.8% |
| Q2 2015 | $393,000 | +14.6% | 11,927 | 0.0% | 0.03% | -7.1% |
| Q1 2015 | $343,000 | -68.1% | 11,927 | -69.7% | 0.03% | -68.5% |
| Q4 2014 | $1,074,000 | +7.4% | 39,427 | -16.0% | 0.09% | 0.0% |
| Q3 2014 | $1,000,000 | – | 46,927 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 25,250 | $784,000 | 2.30% |
| Global Alpha Capital Management Ltd. | 418,030 | $12,976,000 | 1.40% |
| AIMZ Investment Advisors, LLC | 70,588 | $2,191,000 | 1.05% |
| PALISADE CAPITAL MANAGEMENT, LP | 566,080 | $17,571,000 | 0.48% |
| RICE HALL JAMES & ASSOCIATES, LLC | 261,533 | $8,118,000 | 0.39% |
| EARNEST PARTNERS LLC | 1,844,621 | $57,257,000 | 0.38% |
| SummerHaven Investment Management, LLC | 14,476 | $449,000 | 0.30% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,085,874 | $33,706,000 | 0.26% |
| Ridgewood Investments LLC | 10,004 | $311,000 | 0.24% |
| DUALITY ADVISERS, LP | 65,650 | $2,038,000 | 0.20% |